CALL/AMGEN/500/0.1/21.06.24 Share Price

Warrant

DE000GG1XEG4

Market Closed - BOERSE MUENCHEN 11:55:29 17/05/2024 pm IST
0.008 EUR 0.00% Intraday chart for CALL/AMGEN/500/0.1/21.06.24
1 month-33.33%
3 months+166.67%
Date Price Change
17/24/17 0.008 0.00%
16/24/16 0.008 0.00%
15/24/15 0.008 +14.29%
14/24/14 0.007 +16.67%
13/24/13 0.006 -25.00%

Real-time BOERSE MUENCHEN

Last update May 17, 2024 at 11:55 pm IST

More quotes

Static data

Product typeWarrants
Buy / SellCALL
Underlying AMGEN INC.
Issuer Goldman Sachs
WKN GG1XEG
ISINDE000GG1XEG4
Date issued 05/01/2024
Strike 500 $
Maturity 21/06/2024 (35 Days)
Parity 10 : 1
Emission price 0.01
Emission volume N/A
Settlement règlement en espèces
Currency EUR

Technical Indicators

Highest since issue 0.025
Lowest since issue 0.002
Delta0.03x
Omega 11.52
Premium60.31x
Gearing338.18x
Moneyness 0.6249
Difference Strike 187.5 $
Difference Strike %+37.51%
Spread 0.15
Spread %93.75%
Theoretical value 0.0810
Implied Volatility 76.65 %
Total Loss Probability 98.11 %
Intrinsic value 0.000000
Present value 0.0810
Break even 500.88 €
Theta-0.04x
Vega0.01x
Rho0x

Company Profile

Amgen Inc. is one of the world's leading biotechnology groups. Net sales break down by source of revenue as follows: - drug sales (94.2%): drugs for treating cancer, metabolic disorders, bone diseases, renal failure, hemophilia, etc.; - other (5.8%): primarily royalties. The United States account for 70.3% of net sales.
Sector
-
More about the company

Ratings for Amgen Inc.

Trading Rating
Investor Rating
ESG Refinitiv
C+
More Ratings

Consensus: Amgen Inc.

Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
29
Last Close Price
312.5 USD
Average target price
314.1 USD
Spread / Average Target
+0.51%
Consensus
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW